Re: Req-40388

1 Application for Senior Manager, Statistical Programming

1.1 Key Areas to demonstrate why I’m a good fit for this role and what I understand a successful candidate should possess.

1.1.1 Leadership in Statistical Programming, Project Management

  • Led teams of programmers in developing analysis datasets across multiple clinical trials. @Veritas, partycity.com
  • Mentored teams and fostered a data-driven culture @Veritas

  • Highlight my project management leadership skills in handling complex data solutions @Veritas

1.1.2 Technical Expertise in SAS & Statistical Tools

  • My proficiency in SAS and R, ensuring efficient programming and functional reporting

  • My ability to optimize statistical models for clinical study reports and regulatory submissions

1.1.3 Regulatory & Compliance Knowledge

  • Demonstrate your understanding of GCP, ICH, FDA, and ISO guidelines in a Pharmaceutical/Medical Device setting.

  • Explain how you ensure data integrity and compliance in statistical programming.

1.1.4 Cross-Functional Collaboration

  • Showcase your ability to partner with statisticians, clinical teams, and regulatory affairs to align programming with study objectives.

  • Highlight how you’ve streamlined workflows for efficient data analysis. @Atlassian, @AutoZone, @Veritas

Here is my proposed plan to get up to speed in the first 90 days ‼️

1.2 Phase 1: Regulatory & Clinical Trial Fundamentals (Weeks 1–3)

Key Learning Areas:

  • Clinical Trial Phases (I-IV) – Understand statistical needs at each stage.

  • Study Designs - Randomization, stratification, adaptive trials.

  • Endpoints & Statistical Analysis - Primary vs. secondary endpoints, survival analysis.

  • FDA Submission Process - Structure of clinical trial data for review.

    • Good Clinical Practice (GCP) – Ethical and scientific quality standards for clinical trials.

    • International Council for Harmonisation (ICH) Guidelines – Covers statistical principles (E9) and trial design (E6).

    • FDA Statistical Guidance – Ensures compliance with regulatory expectations.

    • ISO Standards – Relevant for medical device trials.

Action Items:

  • Summarize key FDA/ICH/CDISC regulations for compliance.

  • Review case studies on statistical analysis in real clinical trials.

1.3 Phase 2: Mastering SAS for Clinical Trial Programming (Weeks 4–6)

Key Learning Areas:

  • CDISC Data Standards (SDTM & ADaM) - FDA requires submission in this format.

  • Clinical Trial Data Manipulation - Creating datasets that meet FDA requirements.

  • Statistical Analysis & Reporting - TLFs (Tables, Listings, Figures)

  • Validation & QC Processes - Ensuring accuracy before submission.

Essential SAS Packages & Techniques:

  • SAS/STAT - Advanced statistical modeling.

  • PROC MIXED, PROC PHREG - Survival analysis & longitudinal data.

  • PROC GLM, PROC GENMOD - Regression models.

  • PROC REPORT - Creating FDA submission-ready reports.

  • PROC SQL - Data manipulation & merging clinical datasets.

Already possessed SAS Clinicial Trial Programmer credentials: Obtained in Nov 2011, Plus, have 8+ years of experience programming in SAS.

Action Items:

  • Practice creating SDTM and ADaM datasets using SAS macros.

  • Develop FDA-compliant TLFs (Tables, Listings, Figures).

1.4 Phase 3: Leveraging R for Clinical Data Analysis (Weeks 7–9)

Key Learning Areas:

  • Survival Analysis (Kaplan-Meier, Cox Models) – Key for clinical trials.

  • Longitudinal & Repeated Measures Models - Handling patient follow-ups.

  • Data Visualization for FDA Reports – Clear presentation of results.

Essential R Packages:

tidyverse – Data manipulation & visualization.

survival – Kaplan-Meier & Cox proportional hazard models.

lme4 – Linear mixed models for longitudinal data.

ggplot2 – High-quality graphics for clinical data.

Hmisc – Descriptive statistics & reporting.

Have 9+ years of extensive R programming experience ‼️

Action Items:

  • Build survival models using R’s survival package.

  • Use ggplot2 to visualize patient outcomes.

1.5 Phase 4: Advanced Techniques & Submission Preparation (Weeks 10–12)

Key Learning Areas:

Action Items:

  • Review real FDA submissions and case studies.

  • Build an end-to-end clinical trial analysis project.

1.6 Appendix

1.6.1 SDTM (Study Data Tabulation Model)

SDTM (Study Data Tabulation Model) is a standardized framework used in clinical trials to organize and format data for regulatory submissions, particularly to agencies like the FDA, EMA, and PMDA. It is developed by CDISC (Clinical Data Interchange Standards Consortium) and is a required format for submitting clinical trial data to the FDA.

1.6.1.1 Why SDTM Matters

  • Standardization – Ensures consistency across clinical trials.
  • Regulatory Compliance – Required for FDA submissions.
  • Efficient Data Review – Helps regulatory agencies analyze trial data faster.
  • Data Sharing & Reuse – Facilitates collaboration across studies.

1.6.1.2 Key Components of SDTM

SDTM organizes data into domains, each representing a different aspect of a clinical trial:

1. Demographics (DM) – Patient characteristics.

2. Adverse Events (AE) – Reports of side effects.

3. Laboratory Data (LB) – Test results.

4. Vital Signs (VS) – Blood pressure, heart rate, etc.

5. Exposure (EX) – Treatment administration details.

Each dataset follows a structured format with: - Identifier Variables (e.g., subject ID, study ID). - Topic Variables (e.g., lab test name). - Timing Variables (e.g., visit date). - Qualifier Variables (e.g., test results, units).

1.6.1.3 Resources to Learn More

1.6.2 ADaM (Analysis Data Model)

ADaM (Analysis Data Model) is a CDISC (Clinical Data Interchange Standards Consortium) standard used in clinical trials to structure analysis datasets for regulatory submissions, particularly to agencies like the FDA, EMA, and PMDA. It ensures that statistical analyses are traceable, reproducible, and aligned with SDTM (Study Data Tabulation Model).

1.6.2.1 Why ADaM Matters

  • Regulatory Compliance – Required for FDA submissions.
  • Traceability – Links analysis datasets to raw clinical trial data.
  • Efficiency – Streamlines statistical programming for clinical study reports.
  • Standardization – Ensures consistency across trials and sponsors.

1.6.2.2 Key ADaM Dataset Types

  1. ADSL (Subject-Level Analysis Dataset) – Contains one record per subject, including demographics and treatment details.
  2. BDS (Basic Data Structure) – Used for repeated measures, time-to-event, and efficacy analyses.
  3. OCCDS (Occurrence Data Structure) – Handles adverse events, medical history, and concomitant medications.

1.6.2.3 Resources to Learn More